Jonathan Corren
Impact in
- Physiology top 0.05%
- Asthma and respiratory diseases
- Immunology and Allergy top 0.1%
- Allergic Rhinitis and Sensitization
- Food Allergy and Anaphylaxis Research
Papers in
- Physiology 179
- Asthma and respiratory diseases 179
-
- Allergic Rhinitis and Sensitization 44
- Food Allergy and Anaphylaxis Research 4
- Co-authors
- William W. Busse (13 shared papers)Janet M. Griffiths (13 shared papers)Jane R. Parnes (10 shared papers)Niroo Gupta (3 shared papers)Bobby Quentin Lanier (3 shared papers)Angel FowlerTaylor (2 shared papers)Charles G. Irvin (4 shared papers)Allen Adinoff (3 shared papers)
- Journals
- Journal of Allergy and Clinical Immunology (69 papers)Annals of Allergy Asthma & Immunology (26 papers)The Journal of Allergy and Clinical Immunology In Practice (16 papers)Allergy (11 papers)CHEST Journal (9 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Jonathan Corren
229 papers receiving 15.7k citations
Jonathan Corren's Hit Papers
Peers
Comparison fields: 5 of 129
- Physiology 10.6k
- Immunology and Allergy 2k
- Otorhinolaryngology 1.3k
- Dermatology 997
- Immunology 885
Countries citing papers authored by Jonathan Corren
This map shows the geographic impact of Jonathan Corren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Corren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Corren more than expected).
Fields of papers citing papers by Jonathan Corren
This network shows the impact of papers produced by Jonathan Corren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Corren. The network helps show where Jonathan Corren may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonathan Corren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 238 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma Hit paper breakdown → | 2018 | 1596 |
| 2 | Lebrikizumab Treatment in Adults with Asthma Hit paper breakdown → | 2011 | 1296 |
| 3 | Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma Hit paper breakdown → | 2001 | 1078 |
| 4 | Tezepelumab in Adults with Uncontrolled Asthma Hit paper breakdown → | 2017 | 800 |
| 5 | Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma Hit paper breakdown → | 2021 | 779 |
| 6 | Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial Hit paper breakdown → | 2016 | 755 |
| 7 | Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials Hit paper breakdown → | 2020 | 567 |
| 8 | Conjunctivitis in dupilumab clinical trials Hit paper breakdown → | 2019 | 365 |
| 9 | 2015 | 337 | |
| 10 | 2001 | 334 | |
| 11 | 2016 | 331 | |
| 12 | Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma Hit paper breakdown → | 2020 | 324 |
| 13 | 1997 | 288 | |
| 14 | 2005 | 250 | |
| 15 | 2010 | 244 | |
| 16 | 1992 | 243 | |
| 17 | 1992 | 236 | |
| 18 | 2009 | 209 | |
| 19 | 2020 | 208 | |
| 20 | 2020 | 192 |
About Jonathan Corren
Jonathan Corren is a scholar working on Physiology, Immunology and Allergy, Otorhinolaryngology, Dermatology and Immunology, having authored 238 papers that have together received 16.5k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (179 papers), Allergic Rhinitis and Sensitization (44 papers), Dermatology and Skin Diseases (9 papers), Sinusitis and nasal conditions (9 papers), Food Allergy and Anaphylaxis Research (4 papers), Inhalation and Respiratory Drug Delivery (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers) and Respiratory and Cough-Related Research (2 papers). The work is most often cited by research in Physiology (10.6k citations), Immunology and Allergy (2k citations), Otorhinolaryngology (1.3k citations), Dermatology (997 citations) and Immunology (885 citations). Jonathan Corren has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include William W. Busse, Janet M. Griffiths, Jane R. Parnes, Niroo Gupta, Bobby Quentin Lanier, Angel FowlerTaylor, Charles G. Irvin, Allen Adinoff, Giovanni Della Cioppa and Andre van As. Their work appears in journals such as Journal of Allergy and Clinical Immunology, Annals of Allergy Asthma & Immunology, The Journal of Allergy and Clinical Immunology In Practice, Allergy and CHEST Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.